Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene therapies for two...
JHVEPhoto/Shutterstock While the U.S. and the world have largely fast-tracked efforts to develop a vaccine against COVID-19, experts in the field of...
Biotech company Inovio released positive interim data from its Phase I clinical trial of INO-4800, its experimental vaccine against COVID-19. INO-4800 is...
Merck’s checkpoint inhibitor Keytruda (pembrolimzumab) keeps racking up approvals for new indications. This time, the anti-PD-1 therapy was approved by the U.S....
ST. LOUIS, June 30, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc....
Reviewed by Emily Henderson, B.Sc.Jun 29 2020
In new research from the Wake Forest Institute for Regenerative Medicine (WFIRM), scientists have shown that bioengineered...
Reviewed by Emily Henderson, B.Sc.Jun 29 2020
An international team of researchers has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins...
